Metabolomics and network pharmacology reveal partial insights into the hypolipidemic mechanisms of ferulic acid in a dyslipidemia mouse model

IntroductionHyperlipidemia is a condition characterized by abnormal levels of lipids and lipoproteins in the plasma, posing significant health risks. Ferulic acid (FA) is an organic acid with therapeutic properties for diabetes and hyperlipidemia.MethodsTo explore biomarkers for FA treatment of hype...

Descrición completa

Detalles Bibliográficos

Principais autores:	Zhihao Zeng, Guanlin Xiao, Yanchang Liu, Minshan Wu, Xingqin Wei, Canhui Xie, Guangying Wu, Dezheng Jia, Yangxue Li, Sumei Li, Xiaoli Bi
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2024-09-01
Series:	Frontiers in Pharmacology
Assuntos:	ferulic acid hyperlipidemia metabolomics network pharmacology conjoint analysis
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1466114/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!